| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | - | 2.698 | 32.744 | 37.816 |
| Total Income - EUR | - | - | - | - | - | - | - | 2.698 | 32.744 | 37.816 |
| Total Expenses - EUR | - | - | - | - | - | - | - | 197 | 2.654 | 3.705 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | - | 2.501 | 30.089 | 34.111 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | - | 2.422 | 25.315 | 28.738 |
| Employees | - | - | - | - | - | - | - | 0 | 0 | 1 |
Check the financial reports for the company - Neurioana Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | - | 1.580 | 1.023 | 2.110 |
| Current Assets | - | - | - | - | - | - | - | 2.658 | 41.027 | 27.990 |
| Inventories | - | - | - | - | - | - | - | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | - | 0 | 19.763 | 819 |
| Cash | - | - | - | - | - | - | - | 2.658 | 21.264 | 27.171 |
| Shareholders Funds | - | - | - | - | - | - | - | 2.463 | 25.363 | 28.786 |
| Social Capital | - | - | - | - | - | - | - | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | - | 1.776 | 16.749 | 1.537 |
| Income in Advance | - | - | - | - | - | - | - | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Neurioana Med S.r.l.